16th international conference on Campylobacter, Helicobacter and related organism
16th international conference on Campylobacter, Helicobacter and related organism
批准号:
8204251
负责人:
IRVING NACHAMKIN
金额:
$1.2万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-01 至 2012-06-30
关键词:
AddressAnimal ModelAntibiotic ResistanceAreaAwardBacterial InfectionsBioinformaticsBiologicalBiologyCampylobacterCampylobacter infectionCampylobacter jejuniClinical ManagementCollaborationsCommunicationDataDeveloped CountriesDeveloping CountriesDevelopmentDiarrheaDisciplineDiseaseDisease OutbreaksEducational workshopEnvironmentEpidemiologistEpidemiologyEvolutionFood SafetyFosteringFunctional disorderFundingGastritisGenomicsGlycobiologyGoalsGrantGuillain-Barré SyndromeHealthHealth FoodHelicobacterHelicobacter pyloriHumanImmune responseImmunologyInfectionInternationalInterventionInvestigationJapanKnowledgeMarshalMedicineMethodsMolecularNamesNational Institute of Allergy and Infectious DiseaseNational Institute of Diabetes and Digestive and Kidney DiseasesNatural HistoryNobel PrizeOrganismOrganism StrainsPathogenesisPeptic UlcerPreventionProcessProteomicsPublic HealthResearchResearch PersonnelResourcesRobin birdScientistSourceStandardizationStomach CarcinomaStudentsTranslatingTravelUpdateVaccinesVeterinariansWorkanimal ecologyantimicrobialauthoritycomparative genomicsdata exchangefascinategastrointestinalgastrointestinal infectionhuman ecologyimprovedinterestmeetingsmicrobialnext generationnovelpathogenposterspreventrepositoryresistant strainresponsesurveillance strategysymposiumvaccine development
中文摘要
描述(由申请人提供):我们计划于2011年8月28日至9月1日在温哥华举办第16届弯曲杆菌、螺杆菌和相关生物国际研讨会(CHRO)。在过去的25年里,我们在世界各地与该领域的世界领先权威机构举行了会议。这个两年一度的研讨会始于1981年,是一个国际论坛,致力于提高我们对这组迷人的细菌病原体的认识。空肠弯曲菌现已被确定为发达国家和发展中国家细菌性腹泻的主要原因。C.空肠也是格林-巴利综合征的主要病因之一,并继续吸引全世界的广泛研究。弯曲杆菌的基因组/蛋白质组/糖组学研究在理解疾病发病机制和生物学以及生物体方面取得了重要进展。1983年在布鲁塞尔举行的第二次研讨会上,幽门螺杆菌(当时称为幽门弯曲杆菌)被介绍给世界,胃十二指肠疾病的微生物革命开始了。H.幽门螺杆菌与胃炎、消化性溃疡和胃癌的关系现已得到普遍承认。对H.幽门螺杆菌,并希望,手段,以防止或控制似乎是触手可及的,因为很多科学家和临床医生正在努力实现这一目标。鉴于H.幽门螺杆菌的发现,巴里马歇尔和罗宾沃伦被授予2005年诺贝尔医学奖和巴里马歇尔仍然非常积极地与CHRO会议,并在过去的CHRO会议在新泻,日本在2009年的主题演讲。CHRO会议一直是并将继续是介绍弯曲杆菌和螺杆菌研究结果的主要场所。本次会议的目标是1)聚集来自世界各地的初级和高级研究人员,他们专门研究弯曲杆菌,螺杆菌和相关生物体引起的疾病的各个方面。这些领域包括微生物发病机制,基因组学/蛋白质组学/糖组学,感染免疫学,胃肠道病理生理学,临床管理,公共卫生,食品安全,以及人类和动物生态学; 2)由主题演讲人在这些不同领域的概述和更新,他们是该领域的专家,也是发病机制的领军人物; 3)在海报会议和简短的邀请演讲中介绍这些不同领域的研究人员的最新成果; 4)促进新的多学科协作互动,以解决紧迫的发病机制问题,预防和治疗由弯曲杆菌和螺杆菌引起的疾病,5)培养和鼓励来自世界不同地区的年轻科学家积极参与弯曲杆菌和螺杆菌的研究。资金将作为旅费补助金提供给学生和初级研究人员,以实现这一目标。CHRO会议涉及NIAID以及NIDDK和NCI感兴趣的许多领域。CHRO会议的重点是了解弯曲杆菌和螺杆菌感染的自然史,发病机制,宿主和免疫反应。CHRO是介绍开发这些感染疫苗的新工作的主要场所。最后,这些胃肠道病原体的基因组学/蛋白质组学/糖组学分析是CHRO会议上提出的一个新的重要研究领域,有助于我们了解感染的发病机制。
公共卫生相关性:弯曲杆菌和螺杆菌是全球数百万感染的原因,并在资源丰富和资源短缺的国家引起显著的发病率。第16届弯曲杆菌,螺杆菌和相关生物研讨会(CHRO2011)将为学生,初级和经验丰富的研究人员提供一个论坛,介绍新的研究和讨论旨在减少人类这些感染负担的方法。
英文摘要
DESCRIPTION (provided by applicant): We propose to host the 16th International Workshop on Campylobacter, Helicobacter and Related Organisms (CHRO) from August 28 - September 1, 2011 in Vancouver. Over the past 25 years, our meetings have been held around the world with the world's leading authorities in the field. This biennial workshop, started in 1981, is an international forum dedicated to enhancing our knowledge of this fascinating group of bacterial pathogens. Campylobacter jejuni is now firmly established as a major cause of bacterial diarrhea in both developed and developing countries. C. jejuni is also one of the major causes of the Guillain-Barre syndrome and continues attracting intense investigation worldwide. Genomic/proteomic/glycomic research on Campylobacter has made important strides on understanding disease pathogenesis and biology and the organism. At the 2nd workshop in Brussels in 1983, Helicobacter pylori (then named Campylobacter pylori) was introduced to the world and the microbiological revolution of gastroduodenal disease began. The association of H. pylori with gastritis, peptic ulcers and gastric carcinoma is now universally recognized. An understanding of the disease process involving H. pylori and hopefully, the means to prevent or control appears to be within reach as a great many scientists and clinicians are striving towards this end. In recognition of the importance of H. pylori, Barry Marshall and Robin Warren were awarded the Nobel Prize in Medicine in 2005 for their discoveries and Barry Marshall remains very active with CHRO meetings and gave a keynote address at the past CHRO meeting in Niigata, Japan in 2009. CHRO meetings have, and continue to be, the major venue for presenting research findings on Campylobacter and Helicobacter. The goals of this conference are 1) to gather junior and senior investigators from around the world who specialize in areas encompassing all aspects of disease due to Campylobacter, Helicobacter and related organisms. These areas include microbial pathogenesis, genomics/proteomics/glycomics, immunology of infections, gastrointestinal pathophysiology, clinical management, public health, food safety, and human and animal ecology; 2) present overviews and updates in these diverse areas by keynote speakers who are experts in their field both inside the field and leading figures in pathogenesis; 3) present the latest results form investigators in these diverse areas in poster sessions and short invited talks; 4) foster new collaborative multi-disciplinary interactions to address pressing questions of pathogenesis, prevention and treatment of diseases due to Campylobacter and Helicobacter and 5) foster and encourage young scientists from different areas of the world to become actively involved in research on Campylobacter and Helicobacter. Funds will be provided as travel grants to students and junior researchers to accomplish this. CHRO meetings address many areas of interest to NIAID as well as NIDDK and NCI. The CHRO meetings focus on understanding the natural history, pathogenesis, and host and immunological responses to infection by Campylobacter and Helicobacter. CHRO is a major venue for presenting new work on developing vaccines for these infections. Finally, genomics/proteomic/glycomic analysis of these gastrointestinal pathogens are a new and important area of research presented at CHRO meetings that contribute to our understanding of the pathogenesis of infections.
PUBLIC HEALTH RELEVANCE: Project Narrative Campylobacter and Helicobacter are the cause of millions of infections worldwide and cause significant morbidity in both resource -rich and resource-challenged nations. The 16th Workshop of Campylobacter, Helicobacter and Related Organisms (CHRO2011) will provide a forum for students, junior and experienced researchers to present new research and discuss approaches that are aimed in reducing the burden of these infections in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a novel antibody therapy for clostridium difficile infection
-
批准号:7962084
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2010
-
负责人:IRVING NACHAMKIN
-
依托单位:
Development of a novel antibody therapy for clostridium difficile infection
-
批准号:8136259
-
项目类别:
-
资助金额:$23.76万
-
财政年份:2010
-
负责人:IRVING NACHAMKIN
-
依托单位:
14th International CHRO Workshop
-
批准号:7406875
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2007
-
负责人:IRVING NACHAMKIN
-
依托单位:
13th International Campylobacter/Helicobacter workshop
-
批准号:7058473
-
项目类别:
-
资助金额:$2.8万
-
财政年份:2005
-
负责人:IRVING NACHAMKIN
-
依托单位:
IMMUNOBIOLOGY OF CAMPYLOBACTER JEJUNI
-
批准号:3136804
-
项目类别:
-
资助金额:$15.38万
-
财政年份:1988
-
负责人:IRVING NACHAMKIN
-
依托单位:
IMMUNOBIOLOGY OF CAMPYLOBACTER JEJUNI
-
批准号:3136805
-
项目类别:
-
资助金额:$14.67万
-
财政年份:1988
-
负责人:IRVING NACHAMKIN
-
依托单位:
IMMUNOBIOLOGY OF CAMPYLOBACTER JEJUNI
-
批准号:3136799
-
项目类别:
-
资助金额:$14.06万
-
财政年份:1988
-
负责人:IRVING NACHAMKIN
-
依托单位:
海外基金